We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
(+14%)
Cap. Flow
-$1.58B
Cap. Flow
% of AUM
-0.53%
Top 10 Holdings %
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1B |
| 2 |
Apple
AAPL
|
+$797M |
| 3 |
Merck
MRK
|
+$316M |
| 4 |
Amazon
AMZN
|
+$308M |
| 5 |
Medtronic
MDT
|
+$298M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$587M |
| 2 |
NXP Semiconductors
NXPI
|
+$554M |
| 3 |
Meta Platforms (Facebook)
META
|
+$449M |
| 4 |
Intuit
INTU
|
+$433M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.73% |
| 2 | Healthcare | 13.29% |
| 3 | Consumer Discretionary | 13.23% |
| 4 | Financials | 12.2% |
| 5 | Communication Services | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Nurix Therapeutics
NRIX
$2.65B
| $3.25M | ﹤0.01% |
98,841
+31,991
| +48% | +$1.06M |
|
|
NVEE
2252
DELISTED
NV5 Global
NVEE
| $3.23M | ﹤0.01% |
164,196
+4,124
| +3% | +$69.4K |
|
|
ARR
2253
Armour Residential REIT
ARR
$2.36B
| $3.23M | ﹤0.01% |
59,840
-16,336
| -21% | -$841K |
|
2254
Alector
ALEC
$199M
| $3.22M | ﹤0.01% |
212,711
-16,778
| -7% | -$209K |
|
|
FFIC
2255
DELISTED
Flushing Financial
FFIC
| $3.22M | ﹤0.01% |
193,215
+12,358
| +7% | +$171K |
|
|
RPT
2256
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $3.21M | ﹤0.01% |
371,672
-38,179
| -9% | -$258K |
|
2257
Harmonic Inc
HLIT
$1.28B
| $3.21M | ﹤0.01% |
434,652
+24,565
| +6% | +$162K |
|
2258
Apogee Enterprises
APOG
$908M
| $3.2M | ﹤0.01% |
101,038
+4,231
| +4% | +$115K |
|
2259
Argan
AGX
$8.37B
| $3.2M | ﹤0.01% |
71,877
-45
| -0.1% | -$2.02K |
|
|
OSG
2260
Octave Specialty Group
OSG
$222M
| $3.19M | ﹤0.01% |
207,653
+523
| +0.3% | +$7.71K |
|
|
TBI
2261
Trueblue
TBI
$311M
| $3.19M | ﹤0.01% |
170,663
+4,887
| +3% | +$87.9K |
|
2262
Caleres
CAL
$487M
| $3.18M | ﹤0.01% |
203,253
+15,309
| +8% | +$171K |
|
2263
Stoke Therapeutics
STOK
$2.11B
| $3.17M | ﹤0.01% |
51,110
+1,145
| +2% | +$52.5K |
|
|
KE
2264
Kimball Electronics
KE
$628M
| $3.16M | ﹤0.01% |
197,696
-5,550
| -3% | -$78.7K |
|
|
ARCH
2265
DELISTED
Arch Resources, Inc.
ARCH
| $3.16M | ﹤0.01% |
72,220
+1,716
| +2% | +$64.1K |
|
|
QADA
2266
DELISTED
QAD Inc.
QADA
| $3.14M | ﹤0.01% |
49,734
+497
| +1% | +$25.5K |
|
2267
StepStone Group
STEP
$3.82B
| $3.14M | ﹤0.01% |
+78,795
| New | +$2.28M |
|
|
HSII
2268
DELISTED
Heidrick & Struggles
HSII
| $3.13M | ﹤0.01% |
106,456
-29,322
| -22% | -$736K |
|
2269
TotalEnergies
TTE
$190B
| $3.11M | ﹤0.01% |
74,138
+15
| +0% | +$579 |
|
2270
Monarch Casino & Resort
MCRI
$2.23B
| $3.09M | ﹤0.01% |
50,417
+4,560
| +10% | +$229K |
|
2271
PMV Pharmaceuticals
PMVP
$63.5M
| $3.08M | ﹤0.01% |
+50,017
| New | +$1.96M |
|
|
ESPR
2272
DELISTED
Esperion Therapeutics
ESPR
| $3.07M | ﹤0.01% |
118,215
-8,144
| -6% | -$244K |
|
2273
America's Car Mart
CRMT
$26.9M
| $3.07M | ﹤0.01% |
27,916
+726
| +3% | +$73.1K |
|
|
CPRX
2274
DELISTED
Catalyst Pharmaceutical
CPRX
| $3.06M | ﹤0.01% |
916,829
+533,282
| +139% | +$1.79M |
|
|
GTS
2275
DELISTED
Triple-S Management Corporation
GTS
| $3.06M | ﹤0.01% |
143,411
+15,603
| +12% | +$333K |
|
Similar funds
VFT
Nuveen's Q4 2020 Portfolio in Review
As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
- Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
- Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
- Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
- Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
- Nuveen opened 145 new positions and closed 125 in Q4 2020.
- Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.
Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.